AstraZeneca Company Overview & News

How efficacious is the vaccine? The AstraZeneca vaccine has an efficacy of 72% against symptomatic SARS-CoV-2 infection, as shown by the primary

Anglo-Swedish pharmaceutical company AstraZeneca has said it was withdrawing its Covid-19 vaccine Vaxzevria, one of the first produced in

astrazeneca It has 11 R&D centres in five countries and 28 manufacturing sites across 16 countries AstraZeneca sells its medicines to more than 130 countries and its main

astrazeneca Find the latest AstraZeneca PLC stock quote, history, news and other vital information to help you with your stock trading and